David Seitz
Medical · Loveland, CONPI 1235169194
Payments from drug & device makers
Across 543 payments — averaging $20.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- AbbVie$2K
- Novartis$969
- Regeneron Healthcare Solutions, Inc.$962
- Sanofi$825
- Sun Pharmaceutical Industries Inc.$742
- plus $5K from 26 others
What the payments were for
- Food & beverage$10,41792%
- Education$9588%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 70 | $1,538 |
| AbbVie | 80 | $1,522 |
| Novartis | 69 | $969 |
| Regeneron Healthcare Solutions, Inc. | 29 | $962 |
| Sanofi | 30 | $825 |
| Sun Pharmaceutical Industries Inc. | 27 | $742 |
| Amgen | 33 | $622 |
| E.r. Squibb & Sons, L.L.C. | 28 | $597 |
| Lilly USA, LLC | 31 | $505 |
| UCB, Inc. | 18 | $501 |
| LEO Pharma Inc. | 22 | $493 |
| Pfizer | 34 | $491 |
| Incyte Corporation | 17 | $422 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 9 | $170 |
| Galderma Laboratories, L.p. | 9 | $154 |
| Dermavant Sciences, Inc. | 4 | $121 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $112 |
| Boehringer Ingelheim | 5 | $91 |
| Helsinn Therapeutics (U.S.), Inc. | 4 | $76 |
| Janssen Scientific Affairs, LLC | 1 | $65 |
| Arcutis Biotherapeutics, Inc. | 4 | $65 |
| Mylan Institutional Inc. | 2 | $50 |
| Almirall LLC | 2 | $39 |
| VYNE Pharmaceuticals Inc. | 2 | $37 |
| Convatec Inc. | 1 | $34 |
| EPI Health, LLC | 2 | $32 |
| Journey Medical Corporation | 1 | $31 |
| Organon | 3 | $29 |
| Biocon Biologics Inc | 1 | $24 |
| Dermira, Inc. | 1 | $22 |
| Kyowa Kirin, Inc. | 1 | $18 |
| Genentech USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,375 in reported general payments places this provider in the 95th percentile of 766 medical providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 154 | $5,057 |
| Fluorouracil | 72 | $4,737 |
| Doxycycline Monohydrate | 117 | $3,225 |
| Ciclopirox | 41 | $2,313 |
| Triamcinolone Acetonide | 103 | $1,599 |
| Dapsone | 13 | $858 |
| CiclopiroxCiclopirox Olamine | 26 | $724 |
| Doxycycline Hyclate | 25 | $662 |
| Ketoconazole | 40 | $553 |
| Metronidazole | 11 | $489 |
| Terbinafine Hcl | 26 | $226 |
| ValacyclovirValacyclovir Hcl | 17 | $212 |
| Mupirocin | 23 | $198 |
| Clindamycin Hcl | 18 | $152 |
| Mometasone Furoate | 13 | $118 |
Paid to pharmacies, not to this prescriber.
Other medical in Loveland
- Christen KutzColorado Springs$2.4M
- Amanda MixonFort Collins$342K
- Kristin RyggColorado Springs$255K
- Jordan MastDenver$247K
- John NovakAurora$173K
- Michelle BarnettColorado Springs$138K
- Michael JacobsonFort Collins$131K
- Lindsey TunstallAurora$87K
- Jennifer NafzigerHighlands Ranch$80K
- Daniel TaylorDenver$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.